Skip to main content

David Page

Duke Health Distinguished Professor of Biostatistics & Bioinformatics
Biostatistics & Bioinformatics, Division of Biostatistics
Duke Box 2721, Durham, NC 27710
2424 Erwin Road Suite 1102, 11072 Hock Plaza, Durham, NC 27705

Overview


David Page works on algorithms for data mining and machine learning, as well as their applications to biomedical data, especially de-identified electronic health records and high-throughput genetic and other molecular data. Of particular interest are machine learning methods for complex multi-relational data (such as electronic health records or molecules as shown) and irregular temporal data, and methods that find causal relationships or produce human-interpretable output (such as the rules for molecular bioactivity shown in green to the side).

Current Appointments & Affiliations


Duke Health Distinguished Professor of Biostatistics & Bioinformatics · 2025 - Present Biostatistics & Bioinformatics, Division of Biostatistics, Biostatistics & Bioinformatics
Professor of Biostatistics & Bioinformatics · 2021 - Present Biostatistics & Bioinformatics, Division of Biostatistics, Biostatistics & Bioinformatics
Professor of Computer Science · 2021 - Present Computer Science, Trinity College of Arts & Sciences
Chair of Biostatistics & Bioinformatics · 2019 - Present Biostatistics & Bioinformatics, Division of Biostatistics, Biostatistics & Bioinformatics

In the News


Published May 4, 2023
Duke Awards 44 Distinguished Professorships
Published February 21, 2023
ChatGPT Is Here to Stay. What Do We Do With It?

View All News

Recent Publications


Pathogenic Genomic Alterations in Circulating Tumor DNA Predict Overall Survival in Men with Metastatic Castrate-resistant Prostate Cancer.

Journal Article Eur Urol · April 2026 BACKGROUND AND OBJECTIVE: Although validated prognostic models exist for men with metastatic castration-resistant prostate cancer (mCRPC), current tools do not incorporate genomic biomarkers such as circulating tumor DNA (ctDNA) aneuploidy or pathogenic ge ... Full text Link to item Cite

The LURN Study-What Have We "LURN"ed So Far?

Journal Article Neurourology and urodynamics · April 2026 LURN was established by the NIDDK to study LUTS with a holistic approach, focusing on urinary urgency. LURN has developed patient-reported outcome instruments to better measure LUTS in men and women. LURN SI-29 can be used for clinical research. LURN SI-10 ... Full text Cite

Stratifying Risk and Treatment Benefit: A Model Predicting Overall Survival in Men with Metastatic De Novo Hormone-sensitive Prostate Cancer in Trials Investigating Docetaxel (the STOPCAP Collaboration).

Journal Article Eur Urol Focus · February 18, 2026 BACKGROUND AND OBJECTIVE: This study aimed to develop and validate a prognostic model for overall survival (OS) in men with de novo metastatic hormone-sensitive prostate cancer (mHSPC), using clinical factors from phase 3 trials to improve survival predict ... Full text Link to item Cite
View All Publications

Recent Grants


Advancing a Holistic Understanding of Variability in Lived Experience with Sickle Cell Pain

ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2025 - 2030

Deprescribing Decision-Making using Machine Learning Individualized Treatment Rules to Improve CNS Polypharmacy

ResearchCo Investigator · Awarded by National Institutes of Health · 2024 - 2029

Integrated Detection and Classification of Sepsis via Tensor Methods Using EHR

ResearchCo Investigator · Awarded by National Heart, Lung, and Blood Institute · 2024 - 2029

View All Grants

Education


University of Illinois · 1993 Ph.D.